Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial

BACKGROUND: When chemotherapy is indicated in patients with early breast cancer, regimens that contain anthracyclines and taxanes are established standard treatments. Gemcitabine has shown promising effects on the response and prognosis in patients with metastatic breast cancer. The SUCCESS-A trial...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res
Autori principali: de Gregorio, Amelie, Häberle, Lothar, Fasching, Peter A., Müller, Volkmar, Schrader, Iris, Lorenz, Ralf, Forstbauer, Helmut, Friedl, Thomas W. P., Bauer, Emanuel, de Gregorio, Nikolaus, Deniz, Miriam, Fink, Visnja, Bekes, Inga, Andergassen, Ulrich, Schneeweiss, Andreas, Tesch, Hans, Mahner, Sven, Brucker, Sara Y., Blohmer, Jens-Uwe, Fehm, Tanja N., Heinrich, Georg, Lato, Krisztian, Beckmann, Matthias W., Rack, Brigitte, Janni, Wolfgang
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583247/
https://ncbi.nlm.nih.gov/pubmed/33097092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01348-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi